...
【24h】

No gastroenteric Bocaviras in high risk patients stool samples

机译:高危患者粪便样本中无胃肠道博卡维拉斯

获取原文
获取原文并翻译 | 示例
           

摘要

Human bocavirus (HBoV) was first described in 2005.The finding resulted from the intensive investigation of nasopharyngeal aspirates (NPAs) obtained from mostly pediatric patients suspected of acute respiratory tract infections (ARTIs). Thus HBoV joined the ranks of viruses colloquially termed "respiratory viruses" because it appears to be predominantly detected in, and associated with, infection of the respiratory tract.The recent studies by Vicente et al. and Albuquerque et al. susascted the human bocavirus to be a putative causative agent of gastroenteritis in children. These researchers investigated the presence of HBoV-DNA in 527 stool samples from patients (<36 month of age) with gastroenteritis-unrelated respitatory symptoms. Of these stool samples, 48 (9.1%) were positive for HBoV-DNA.10 The frequency of HBoV-DNA positive fecal specimen investigated by Albuquerque and coworkers was 2% (14/705). In contrast, Lee et al. described a percentage of 0.8% HBoV-DNA positive specimen in their study, suggesting that at least in some populations HBoV may play only a minor role in gastroenteritis. However, a close tax-onomic relationship exists between HBoV and bovine-parvovirus, an animal virus capable of causing gastrointestinal symptoms in cattle.6 Taking this into account, and taking into account the nature of parvovirus particles, it appears likely that the virus can pass through and eventually infect the gastrointestinal tract, as patients frequently swallow virus-containing sputum or nasal secretions. Nevertheless, despite a final proof for the assumption by Brieu et al.4, is missing as neither a cell culture nor an animal model have been described, nucleic acid amplification methods remain the sole diagnostic tool for the detection of bocavirus. Instead of PCR, nucleic acid sequence-based amplification (NASBA) may serve as an alternative detection method. In order to establish NASBA as an alternative to PCR amplification and to confirm PCR results, we made use of the basic open platform NucliSens EasyQ according to the manufacturer's recommendations.
机译:人类博卡病毒(HBoV)于2005年首次被描述,该发现来自对疑似急性呼吸道感染(ARTIs)的大部分儿科患者的鼻咽抽吸物(NPA)的深入研究。因此,HBoV加入了俗称“呼吸道病毒”的病毒行列,因为它似乎主要在呼吸道感染中检测到并与之相关。Vicente等人的最新研究。和Albuquerque等。推举人类博卡病毒是儿童胃肠炎的推定病原体。这些研究人员调查了527例粪便样本中HBoV-DNA的存在,这些样本来自与胃肠炎无关的呼吸道症状(<36个月大)。在这些粪便样本中,有48(9.1%)的HBoV-DNA阳性。10由Albuquerque和同事调查的HBoV-DNA阳性粪便样本的频率为2%(14/705)。相反,李等人。在他们的研究中,HBoV描述了0.8%的HBoV-DNA阳性标本百分比,这表明至少在某些人群中,HBoV在胃肠炎中可能只起较小的作用。但是,HBoV与牛细小病毒(一种能够在牛中引起胃肠道症状的动物病毒)之间存在紧密的税收-经济学关系。6考虑到这一点,并考虑细小病毒颗粒的性质,这种病毒似乎可以由于患者经常吞咽含病毒的痰或鼻分泌物,因此会通过并最终感染胃肠道。然而,尽管没有对Brieu等人[4]的假设提供最终证据,但由于既没有描述细胞培养物也没有动物模型,核酸扩增方法仍然是检测博卡病毒的唯一诊断工具。代替PCR,基于核酸序列的扩增(NASBA)可用作替代检测方法。为了建立NASBA作为PCR扩增的替代方法并确认PCR结果,我们根据制造商的建议使用了基本的开放平台NucliSens EasyQ。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号